Clinical trial
Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons…
NCT00272688 · University Hospital, Akershus, Other · Completed
Key facts
| NCT number | NCT00272688 |
|---|---|
| Title | Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit |
| Official title | Continuous Delivery of Levodopa/Carbidopa (Duodopa) in Patients With Advanced Idiopathic Parkinsons Disease - a Health Economic Evaluation |
| Lead sponsor | University Hospital, Akershus, Other |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | Levodopa (drug), intraduodenal administration |
| Enrollment | 10 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Jan 9, 2006 |
| Last update posted | Dec 30, 2015 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: